- Home
- About Us
- Advisory Board
- Products
- Services
- News
- Distributors
- Contact Us
- Search
- Lot I-10-7, D7 Street, Saigon Hi-Tech Park, Tang Nhon Phu Ward, Thu Duc City, HCMC(+84) 28 7301 3688Info@wembleymed.com.vn
Platelet-Rich Plasma (PRP) has emerged as one of the most promising and notable therapeutic options in the treatment of tendinitis, particularly in cases of chronic, persistent, or recurrent tendinopathy, where conventional treatment approaches have failed to achieve satisfactory outcomes.
At the seminar titled “THE ROLE OF PLATELET-RICH PLASMA IN THE TREATMENT OF MUSCULOSKELETAL DISORDERS” (July 26, 2025), MSc. Dr. Bui Dang Khoa, a musculoskeletal specialist from University Medical Center Ho Chi Minh City, explored the “Application of PRP in the Treatment of Tendinitis”, discussing clinical case studies and treatment outcomes.
The presentation provided practical, evidence-based insights, offering clinicians and specialists new perspectives and effective strategies for the clinical application of PRP.

Please find the detailed presentation of the report in the slides below.
MSc. Dr. Bui Dang Khoa
Department of Neurosurgery
University Medical Center Ho Chi Minh City
MSc. Dr. Bui Dang Khoa has over 10 years of clinical experience and has received formal training both domestically and internationally. He specializes in musculoskeletal ultrasonography, joint and tendon injections, and the management of musculoskeletal disorders.
He is currently working at the Department of Rheumatology, University Medical Center Ho Chi Minh City.

For any inquiries related to the professional content of the presentation, please contact us via email at info@wembleymed.com.vn or hotline +84 963 797 072. Questions will be compiled and forwarded to MSc. Dr. Bui Dang Khoa for further clarification.
To receive the PDF files, including the presentation content and professional insights on the application of PRP in the treatment of musculoskeletal disorders, please click to register your information below. The materials will be sent to your registered email address.
